Many people in the UK discuss medical cannabis, but a lot of misinformation still exists. Misconceptions can cause unnecessary worry. This article looks at the facts to help you understand how medical cannabis works under UK law.

In the UK, specialists can legally prescribe cannabis-based products for medicinal use (CBPMs) under specific, strict conditions. Knowing the reality behind the common myths can help you have clearer conversations with your doctor.

Myth 1: Medical cannabis is highly addictive

One major worry about medical cannabis is the risk of addiction. While cannabis contains active compounds, medical data shows the risk of dependence is different from what many people assume.

• Regulated care lowers risk: Patients use medical cannabis within a controlled system. Specialist doctors monitor your progress, adjust your plan and help prevent misuse.

• Controlled ingredients: Street cannabis often contains unknown, high levels of THC (tetrahydrocannabinol), the compound that causes a "high". Medical cannabis uses regulated, precise ratios of active ingredients tailored to your specific clinical needs.

Myth 2: Medical cannabis always causes impairment

Another common myth is that medical cannabis will always impair your daily cognitive function.

Medical treatments aim to minimise unwanted side effects while managing symptoms. Doctors carefully adjust your dosage and delivery methods to avoid significant impairment.

Furthermore, many medical cannabis options contain high levels of CBD (cannabidiol) and very low levels of THC. CBD does not cause the intoxicating "high" associated with recreational cannabis. Clinical studies show that low-to-moderate doses with this balance are unlikely to cause impairment. Patients must always follow their specialist's instructions regarding when and how to take their medication.

Myth 3: Medical cannabis causes severe long-term side effects

Patients frequently worry about long-term risks before starting any new prescription medication.

Evidence suggests that the long-term risks of supervised medical cannabis are relatively low, particularly when compared to some traditional prescription options. Most recorded side effects are mild and temporary.

A study published in the Journal of Pain followed medical cannabis patients over one year. The researchers reported only mild adverse effects and found no significant negative impact on the patients' cognitive function.

Important distinction: You cannot compare unregulated recreational use with care supervised by a registered doctor. Medical cannabis paths focus on patient safety through regular clinical reviews.

By separating fact from fiction and relying on clinical data, patients can better understand the true safety profile of supervised medical treatments. Consulting a registered specialist remains the essential first step to ensuring a safe, legal and tailored care plan that works for you.

Last updated 12 August 2026